[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL180846A0 - 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors - Google Patents

1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Info

Publication number
IL180846A0
IL180846A0 IL180846A IL18084607A IL180846A0 IL 180846 A0 IL180846 A0 IL 180846A0 IL 180846 A IL180846 A IL 180846A IL 18084607 A IL18084607 A IL 18084607A IL 180846 A0 IL180846 A0 IL 180846A0
Authority
IL
Israel
Prior art keywords
hetero
heterocyclylethanes
arylethanes
tetra
tri
Prior art date
Application number
IL180846A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL180846A0 publication Critical patent/IL180846A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL180846A 2004-07-29 2007-01-21 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors IL180846A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29
PCT/US2005/026334 WO2006028590A1 (en) 2004-07-29 2005-07-25 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Publications (1)

Publication Number Publication Date
IL180846A0 true IL180846A0 (en) 2007-06-03

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
IL180846A IL180846A0 (en) 2004-07-29 2007-01-21 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Country Status (15)

Country Link
KR (1) KR20070043985A (ru)
AR (1) AR049847A1 (ru)
BR (1) BRPI0513793A (ru)
CR (1) CR8876A (ru)
EC (1) ECSP077208A (ru)
IL (1) IL180846A0 (ru)
MA (1) MA28980B1 (ru)
MX (1) MX2007001188A (ru)
NO (1) NO20071107L (ru)
PE (1) PE20060382A1 (ru)
RU (1) RU2344134C2 (ru)
TW (1) TW200607493A (ru)
UA (1) UA88018C2 (ru)
WO (1) WO2006028590A1 (ru)
ZA (1) ZA200700477B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2408440B1 (en) * 2009-03-18 2016-05-11 Medicure International Inc. Transdermal pharmaceutical preparation and administration of tirofiban
CA2876359C (en) 2012-06-11 2020-01-21 Bristol-Myers Squibb Company Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino) quinazolin-2-yl] pyridine-3-sulfonamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE400551T1 (de) * 2002-01-04 2008-07-15 Neurosearch As Kaliumkanal-modulatoren

Also Published As

Publication number Publication date
RU2007107408A (ru) 2008-09-10
CR8876A (es) 2007-08-28
TW200607493A (en) 2006-03-01
UA88018C2 (ru) 2009-09-10
MA28980B1 (fr) 2007-11-01
RU2344134C2 (ru) 2009-01-20
KR20070043985A (ko) 2007-04-26
MX2007001188A (es) 2007-03-21
PE20060382A1 (es) 2006-05-15
WO2006028590A1 (en) 2006-03-16
BRPI0513793A (pt) 2008-05-13
ZA200700477B (en) 2009-08-26
NO20071107L (no) 2007-04-19
ECSP077208A (es) 2007-02-28
AR049847A1 (es) 2006-09-06

Similar Documents

Publication Publication Date Title
ZA200407666B (en) Pyridinoylpiperidines as 5-HTif agonists.
ZA200610142B (en) Furanopyrimidine compounds effective as potassium channel inhibitors
TWI369351B (en) 2,4-diamino-pyrimidines as aurora inhibitors
HK1209729A1 (en) Compounds, compositions and methods
EP1781635A4 (en) POTASSIUM CHANNEL INHIBITORS
HRP20130810T1 (en) Sulphonylpyrroles as hdac inhibitors
AP2005003474A0 (en) Compositions and methods for increasing telomeraseactivity.
ZA200502210B (en) Substrates for O6-alkylguanine-DNA alkyltansferase.
IL183706A0 (en) 2,4(4,6) pyrimidine derivatives
EP1667683A4 (en) INHIBITORS OF POTASSIUM CHANNELS WITH QUINOLINE
AP2321A (en) Quinoline derivatives for use as mycobactrial inhibitor.
EP1940406A4 (en) POTASSIUM CHANNEL INHIBITORS
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
ZA200307420B (en) Point chisel.
EP1493437A4 (en) COMPOSITIONS AGAINST DIABETES
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
WO2006009649A3 (en) Brassica indehiscent1 sequences
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
HK1115878A1 (en) (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
EP1667973A4 (en) INHIBITORS OF THE QUINOLINE POTASSIUM CANAL
IL180846A0 (en) 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors
EP1776355A4 (en) POTASSIUM CHANNEL INHIBITORS
ZA201005086B (en) 4-imidazolidinones as kv1.5 potassium channel inhibitors
ITMI20032493A1 (it) Manovellismo per un compressore alternativo.
ZA200810763B (en) Imidazolidinone Kv1.5 potassium channel inhibitors